fbpx Skip to main content

BioCommunique Article

Companies working on projects or technologies to treat coronavirus are urged to complete the form for Chinese partnerships to be considered.

MyBioGate Puts Out Urgent Call for Coronavirus Treatment Projects

  • 2020-02-13T23:52:00.000+0000
  • California
  • Author: MyBioGate

Due to the wide spread of coronavirus (2019-nCOV) in China, Chinese biopharma & medical device companies and investors are actively seeking relevant drugs, medical devices, and diagnosis to combat the new coronavirus. As the breakout is a serious threat to public health, the China National Medical Products Administration (NMPA, also known as CFDA) has announced to accelerate approval speed for projects associated with the treatment of the virus.

If your company has a project or technology to treat the condition, and would like to seek for Chinese partners/investors, please fill out this form.

Owing to time constraints, the deadline for this application is February 14th. If your project raises interest to our China partners, we will contact you right away to move forward.